Extended Data Fig. 3: Anti-drug antibody (ADA) assay before ART discontinuation.
From: Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
ADA responses were assessed in the PGT121+GS-9620 and PGT121-alone groups every 2 weeks from weeks 106 to 124 using an electrochemoluminescence (ECL) assay with an anti-PGT121 idiotypic mAb (n = 11 monkeys per group). No ADA was detected. One monkey in the PGT121+GS-9620 group had background reactivity in this assay at week 106 before PGT121 exposure (green bars).
